The paper's citation list
No. | The paper's citation list |
|---|
1 | The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review. 2023;24:13961 doi: 10.3390/ijms241813961 |
2 | Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma. 2022;13: doi: 10.3389/fendo.2022.1056310 |
3 | ANTIOXIDANT POTENTIAL OF PERITONEAL FLUID IN OVARIAN CANCER. 2024;8:63 doi: 10.29039/rusjbpc.2023.0590 |
4 | Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance. 2022;12: doi: 10.1038/s41598-022-20976-0 |
5 | Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells. 2021;16:e0258363 doi: 10.1371/journal.pone.0258363 |
6 | Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer. 2020;7: doi: 10.3389/fcell.2019.00371 |
7 | Emerging Role of Metabolomics in Ovarian Cancer Diagnosis. 2020;10:419 doi: 10.3390/metabo10100419 |
8 | Convergence of Plasma Metabolomics and Proteomics Analysis to Discover Signatures of High-Grade Serous Ovarian Cancer. 2020;12:3447 doi: 10.3390/cancers12113447 |
9 | Unravelling the Mechanism of Cisplatin Resistance in Triple-Negative Breast Cancer: Insights from Metabolomic Profiling via Mass Spectrometry Analysis. 2025;36:1227 doi: 10.1021/jasms.4c00445 |
10 | Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models. 2024;11: doi: 10.3389/fchem.2023.1332816 |
11 | Synergistic effect of the sphingosine kinase inhibitor safingol in combination with 2'-nitroflavone in breast cancer. 2024;102:1503 doi: 10.1007/s00109-024-02497-7 |
12 | Drug Resistance: The Role of Sphingolipid Metabolism. 2025;26:3716 doi: 10.3390/ijms26083716 |
13 | Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. 2022;12:351 doi: 10.3390/life12030351 |
14 | Integrated transcriptomic and metabolomic investigation of the genes and metabolites involved in swine follicular cyst formation. 2024;10: doi: 10.3389/fvets.2023.1298132 |
15 | New insights into the roles and regulation of SphK2 as a therapeutic target in cancer chemoresistance. 2019;234:8162 doi: 10.1002/jcp.27612 |
16 | Metabolic Plasticity in Chemotherapy Resistance. 2020;10: doi: 10.3389/fonc.2020.00281 |
17 | Metabolism-associated marker gene-based predictive model for prognosis, targeted therapy, and immune landscape in ovarian cancer: an integrative analysis of single-cell and bulk RNA sequencing with spatial transcriptomics. 2025;25: doi: 10.1186/s12905-025-03750-y |
18 | Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma. 2022;13: doi: 10.3389/fendo.2022.1045167 |
